LCOM & Department News

Tracy to Play Role in NIH Study of Molecular Changes during Physical Activity

December 16, 2016 by Jennifer Nachbur

The National Institutes of Health (NIH) Common Fund has announced the first awards for its Molecular Transducers of Physical Activity in Humans Program, which will allow researchers to develop a comprehensive map of the molecular changes that occur in response to physical activity and uncover findings that could lead to people engaging in more targeted and optimized types of activity.

Russell Tracy, Ph.D., Professor of Pathology and Laboratory Science, Larner College of Medicine at UVM (Photo: LCOM Design & Photography)

The National Institutes of Health (NIH) Common Fund has announced the first awards for its Molecular Transducers of Physical Activity in Humans Program, which will allow researchers to develop a comprehensive map of the molecular changes that occur in response to physical activity and uncover findings that could lead to people engaging in more targeted and optimized types of activity.

Nineteen grants totaling approximately $170 million through fiscal year 2022 (pending availability of funds) will support researchers across the country – including Russell Tracy, Ph.D., of the Larner College of Medicine at the University of Vermont. The awardees will work as a consortium to develop plans for recruitment into clinical trials, identification of methods to analyze tissue samples, and selection of animal models to best replicate human studies. Animal models will allow researchers to search for changes in tissues not easily accessible in human patients, such as the brain, lungs, and kidneys. 

“We have long understood that exercising is beneficial to our overall health, but don't fully understand the impact of exercise at the molecular level,” said NIH Director Francis S. Collins, M.D., Ph.D., in a press release issued by the NIH on December 13, 2016. “The development of a so-called molecular map of circulating signals produced by physical activity will allow us to discover, at a fundamental level, how physical activity affects our health. This knowledge should allow researchers and doctors to develop individually targeted exercise recommendations and better help those who are unable to exercise.” (Learn more about the MoTrPAC program in this video interview from Dr. Collins.)

Seven clinical centers across the country (six for adult participants, and one for those younger than 18 years of age) will recruit people from diverse racial and ethnic groups beginning in 2018. They will examine how molecular signals are altered following changes in exercise patterns. (Find more information about the sites.)

In addition to the clinical trial sites, the Molecular Transducers of Physical Activity Consortium (MoTrPAC) will include seven chemical analysis sites, three awards to conduct physical activity studies in animal models, a bioinformatics center to disseminate data and tools to the entire research community, and a coordination center to harmonize activities across the Consortium. The program will also provide funding to store data in a user-friendly public resource that any researcher can access to investigate the molecular mechanisms through which physical activity can improve or preserve health.

Tracy and his Vermont team will be supported by roughly $1.2 million in funding from the Consortium’s Coordinating Center’s $10 million award over the project period. In collaboration with the Coordinating Center, Tracy’s lab at UVM will work with MoTrPAC investigators and the analytical sites to standardize biological specimen collection methods; ensure the protocols are written in a standardized manner; oversee the collection of the biological specimens; develop quality control procedures; receive the biological specimens and store them in state-of-the-art ultracold freezers and liquid nitrogen tanks; help develop ancillary study procedures and methods. His group will then distribute these biological specimens to the MoTrPAC investigators, as well as other investigators who wish to conduct studies related to this large-scale exploration of the biochemical effects of exercise.

“This is an unprecedented large-scale effort to begin to explore – in extreme detail – the biochemical, physiological and clinical impact of exercise,” said Tracy, who is a professor of pathology and laboratory science and biochemistry. “I’m pleased and honored that our lab at UVM was chosen to be the MoTrPAC Biorepository, and anticipate that the MoTrPAC ‘maps,’ when coupled with the carefully collected biosamples, will prove enormously useful over the next decade or more of additional studies.”

MoTrPAC is funded through the NIH Common Fund and managed by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute on Aging, and National Institute of Biomedical Imaging and Bioengineering. Awards are made using the NIH Cooperative Agreement mechanism which allows for substantial scientific interaction between the NIH and awardees.

About the NIH Common Fund
The NIH Common Fund encourages collaboration and supports a series of exceptionally high-impact, trans-NIH programs. Common Fund programs are designed to pursue major opportunities and gaps in biomedical research that no single NIH institute could tackle alone, but that the agency as a whole can address to make the biggest impact possible on the progress of medical research. Additional information about the NIH Common Fund can be found at http://commonfund.nih.gov.

About the National Institutes of Health (NIH)
NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about the NIH and its programs, visit http://www.nih.gov.

(This article was adapted from a press release produced by the NIH Common Fund.)

Department Highlights

Department alumni, Dr. Bobbi Pritt, M.D. featured in Vermont Medicine Magazine. To read her story click on the photo below.

Pritt_small


 

 

Dr's Leonard and HuberA Remarkable Gift from Dr. Sally Huber, Ph.D.

At the end of last week's Research Day, Dr. Leonard gave a surprise announcement: a very generous bequethment of $5 million by research faculty emerita, Dr. Sally Huber! The funds will go toward two endowed professorships for junior investigators in our department. The endowments will be named for her parents, Elmer R. Huber and Blodwen S. Huber, and will support junior research faculty for five years.(9/2018)

This amazing support will allow junior faculty time and funds to gain independence while pursuing the milestone achievement of being awarded their first R01 grant.

 

Heintz Awarded 2018 Distinguised Graduate Alumni Award

Dr. Nick Heintz, Ph.D. received the 2018 UVM Medical Alumni Association’s Distinguished Graduate Alumni Award​, which is presented to Larner College of Medicine (LCOM) alumni who have demonstrated outstanding achievement in basic, clinical or applied research; education; industry; public service/humanitarianism; and/or outstanding commitment to the LCOM community.

He accepted his award at the college's Celebrating Research Excellence event at the end of October. (September 2018)

Kida Received Certificate of Commendation

Dr. Kida receives award from the State of Vermont...read more here. (August 2018)

Leonard and Committee Publish Through National Academies Press

Dr. Debra Leonard, along with a committee under the National Academies of Sciences, Engineering, and Medicine, ​published "Returning Individual Research Results to Participants: Guidance for a New Research Paradigm" through The National Academies Press, Washington, D.C., 2018 (Committee Member). (August 2018)

Excellence in Education

The Larner College of Medicine’s second year medical students nominate and elect faculty who they want to recognize for their outstanding teaching and support over their first years of the Foundations education. (February 2018)

Pathology nominees (winners in bold):

AMWA Gender Equity Award  - Pamela Gibson; Sharon Mount; Rebecca Wilcox

Dean Warhsaw Integration Award - Rebecca Wilcox

Silver Stethoscope Award - Scott Andreson; Maureen Harmon; John Lunde

Above and Beyond Award - Ronald Bryant; Rebecca Wilcox

Foundations Course Director Award -Rebecca Wilcox

Outstanding Foundations Course Award

  • Cardiovascular, Respiratory & Renal Systems: (Ron Bryant; Kelly Butnor; and Pam Gibson are the primary pathologists in each section of the course, respectively)
  • Nutrition, Metabolism & the Gastrointestinal System: Course Director is Rebecca Wilcox

Foundations Teaching Award - Ronald Bryant; Pamela Gibson; Rebecca Wilcox; Christina Wojewoda

Dr. Yvonne Janssen-Heininger Receives Patent

Yvonne Janssen-Heinger was awarded a patent on the ​concept that strategies to inhibit GSTP has utility for the treatment of patients with pulmonary fibrosis. Congratulations, Yvonne! (January 2018)

Drs. Bronwyn Bryant and Phillip Munson inducted into the Teaching Academy

Last week Bronwyn and Phillip were inducted into University of Vermont's Teaching Academy. The Teaching Academy sustains and supports an interdisciplinary community of educators who value the scholarship of teaching and learning while facilitating educator development; improve the efficiency and quality of medical education through collaboration and scholarship; and promote an academic environment that increases the value and impact of educators locally, regionally, and nationally. (January 2018)

Dr. Leonard Video Recording Available 

Dr. Leonard gives a series of talks on Genomic Medicine in Vermont for the Osher Lifelong Learning Institute (OLLI)​. A video recording of the talk is available here >> (October 2017)

Department Members Took Part in the March For Science

Banner carriers: Dr. Debra Leonard, Sara Kwolek & Dr. Sharon Mount. Also, in view are Doug Taatjes,Ph.D., and Dr. Rebecca Wilcox. (April 2017)

Janssen-Heininger Featured Woman in Science

Dr. Yvonne Janssen-Heininger, Ph.D., was chosen as the featured ​Woman in Science by the Society for Redox Biology and Medicine! She got pretty colorful with some of her answers, so definitely worth a read. (March 2017) Read the story >>

Buskiewicz Publishes in Science Signaling

Dr. Iwona Buskiewicz, Ph.D., publishes study in Science Signaling, revealing potential key to alternative Lupus treatment.  (February 2017)

Genomic Medicine Laboratory Grand Opening (January 2017)
Larner College of Medicine Foundations Awards

Pamela Gibson, M.D. won the AMWA Gender Equity Award, which honors a male or female faculty member who promotes a gender-fair environment for the education and training of physicians and gender diversity in the field. Pam is Co-advisor of the Gender and Sexuality Alliance. (January 2017)

Rebecca Wilcox, M.D. won the Foundations Course Director Award, and her Nutrition, Metabolism, and Gastrointestinal System (NMGI) course won Outstanding Foundations Course Award. Rebecca was also nominated for the Foundations Teaching Award. (January 2017)

Mark Fung, M.D., Ph.D. and Andy Goodwin, M.D. were also nominated for the Silver Stethoscope awards, which recognizes the faculty member who had few lecture hours, but made a substantial contribution to students’ education. (January 2017)